The Pharmacy Times® Attention-Deficit Hyperactivity Disorder (ADHD) Resource Center is a comprehensive resource for clinical news and expert insights on issues related to ADHD, a chronic condition that can cause attention difficulty, hyperactivity, and impulsiveness.
February 21st 2025
In a study of 5 different drugs, amlodipine was the only one to reduce hyperactivity in patients with attention-deficit hyperactivity disorder (ADHD).
October 29th 2024
Adverse Reactions to Methylphenidate ADHD Treatment Aren't Serious
February 8th 2015Although children with attention deficit hyperactivity disorder often experience decreased appetite and sleep disturbances during methylphenidate treatment, a study published in the Journal of Research in Pharmacy Practice indicates that those adverse drug reactions (ADRs) are mostly mild and not serious.
Read More
ADHD Patients More Likely to Augment Meds After Receiving Atypical Antipsychotics
January 3rd 2015Stimulant-treated adolescents with attention deficit hyperactivity disorder who switch to atypical antipsychotics show significantly greater drug augmentation, health care resource utilization, and costs compared with their counterparts who switch to nonantipsychotics.
Read More
Vyvanse Receives FDA Priority Review for Expanded Binge Eating Disorder Indication
September 16th 2014The FDA has granted priority review to a supplemental New Drug Application that would expand the use of lisdexamfetamine dimesylate (Vyvanse) to treat adult patients with binge eating disorder.
Read More